Published in Obesity and Diabetes Week, April 17th, 2006
In the 10 major markets, audited growth was 5.7% in 2005, compared with 7.2% the previous year. This group accounts for 81% of the total global pharmaceutical market, but emerging markets (e.g. China, Korea, Mexico, Russia, and Turkey) experienced double-digit growth, outpacing global performance and signaling important shifts in the marketplace.
"As growth in mature markets moderates, industry attention is shifting to smaller, developing markets...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.